Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ovarian reserve markers in women using various hormonal contraceptives

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Concerns on future fertility among users and past-users of combined oral contraceptives: a questionnaire survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hepatotoxicity induced by a second-generation combined oral contraceptive: case report and review of the literature

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. European society of contraception statement on contraception in obese women

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ovarian cortical follicle density in infertile women with low anti-Müllerian hormone

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Therapeutic endometrial scratching and implantation after in vitro fertilization: a multicenter randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Objectives: The aim of the study was to assess whether the ovarian reserve markers anti-Müllerian hormone (AMH) and antral follicle count (AFC) were lower among women using the progestin-only pill (POP) or levonorgestrel-releasing intrauterine system (LNG-IUS) and similar to the decrease observed in combined oral contraceptive (COC) pill users.Methods: This retrospective study comprised 565 hormonal contraceptive users (COC, POP, LNG-IUS or contraceptive vaginal ring) and 983 non-hormonal contraceptive users, who were seen in two Danish fertility assessment and counselling clinics between 2015 and 2019. Adjusted multiple regression analysis was used to examine the differences in AMH and AFC between hormonal and non-hormonal contraceptive users.Results: Compared with non-hormonal contraceptive users, AMH was 31.1% lower among COC users [95% confidence interval (CI) -39.6%, -25.9%; p < 0.001], 35.6% lower among POP users (95% CI -49.0%, -18.6%; p < 0.001) and 17.1% lower among LNG-IUS users (95% CI -31.4%, 0.002%; p = 0.052); no significant differences were seen among vaginal ring users. Compared with non-hormonal contraceptive users, AFC was 31.3% lower among COC users (95% CI -35.0%, -25.3%; p < 0.001) and 29.7% lower among POP users (-39.1%, -17.9%; p < 0.001); no significant differences were seen among LNG-IUS or vaginal ring users. Ovarian volume was more than 50% reduced among COC and vaginal ring users (p < 0.001) but was unchanged among POP and LNG-IUS users.Conclusion: Assessment of ovarian reserve markers among users of all types of hormonal contraception should be interpreted cautiously and the type of contraceptive method considered.

Original languageEnglish
JournalThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Volume25
Issue number1
Pages (from-to)65-71
Number of pages7
ISSN1362-5187
DOIs
Publication statusPublished - Feb 2020

ID: 59199900